The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost-Effectiveness of brentuximab vedotin with chemotherapy in frontline treatment of CD30-expressing peripheral T-cell lymphoma.
 
Tatyana Feldman
Honoraria - Abbvie; Bayer; Bristol-Myers Squibb; Kite, a Gilead company; Pharmacyclics/Janssen; Seagen; Takeda
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Seagen
Speakers' Bureau - Abbvie; Celgene; Janssen; Kite, a Gilead company; Pharmacyclics; Seagen
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Cell Medica (Inst); Eisai (Inst); Kyowa Hakko Kirin (Inst); Kyowa Hakko Kirin (Inst); Pfizer (Inst); Portola Pharmaceuticals (Inst); Roche (Inst); Seagen (Inst); Trillium Therapeutics (Inst); Viracta Therapeutics (Inst); Viracta Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; Kite, a Gilead company; Pharmacyclics; Seagen; Takeda
 
Denise Zou
Research Funding - Seagen
 
Mayvis Rebeira
Employment - Seagen
Stock and Other Ownership Interests - Seagen
 
Joseph Lee
Research Funding - Seagen
 
Mack Harris
Research Funding - Seagen
 
Wenkang Ma
Research Funding - Seagen
 
Michelle A. Fanale
Honoraria - Bristol-Myers Squibb; Plexus; Research to Practice; Seagen; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; Seagen; Spectrum Pharmaceuticals
Research Funding - ADC Therapeutics; Bristol-Myers Squibb; Celgene; Genentech; Gilead Sciences; MedImmune; Merck; Millennium; Molecular Templates; Novartis; Pharmacyclics; Seagen; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Plexus; Research to Practice; Seagen; Spectrum Pharmaceuticals; Takeda
 
Thomas John Manley
Employment - Seagen
Stock and Other Ownership Interests - Seagen
 
Joseph Feliciano
Employment - Seagen
Stock and Other Ownership Interests - Seagen
 
Shangbang Rao
Employment - Bristol-Myers Squibb; Seagen
Stock and Other Ownership Interests - Seagen
 
Anuraag Kansal
Research Funding - Seagen